BFS
ADMA icon

Bare Financial Services’s ADMA Biologics ADMA Stock Holding History

Bare Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.8K Buy
932
+101
+12% +$921 ﹤0.01% 685
2026
Q1 		$7.49K Buy
831
+448
+117% +$7.07K ﹤0.01% 485
2025
Q4 		$6.99K Buy
383
+109
+40% +$1.84K ﹤0.01% 393
2025
Q3 		$4.02K Buy
274
+221
+417% +$3.79K ﹤0.01% 626
2025
Q2 		$965 Buy
+53
New +$1.08K ﹤0.01% 933

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bare Financial Services's ADMA Position: Q2 2026 in Review

Bare Financial Services increased its ADMA Biologics (ADMA) stake by 12% in Q2 2026, buying an estimated $921 and bringing the position to 932 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Bare Financial Services first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Bare Financial Services held 932 shares of ADMA Biologics worth $7.8K as of Q2 2026.
  • Bare Financial Services bought 101 ADMA Biologics shares in Q2 2026, an estimated $921.
  • ADMA Biologics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #685 holding.
  • Bare Financial Services first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.